A company that ‘translates science into survival’ by developing new therapies has completed its acquisition of a technology company leading in artificial intelligence (AI) and machine learning (ML).
/PRNewswire/ Beactica Therapeutics AB, the Swedish precision oncology company, today announced the appointment of Jarl Ulf Jungnelius M.D. to its Board of.
The Ryvu Therapeutics project for RVU120 has a recommendation for PLN 62.27 million in funding from ABM biznespolska.pl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biznespolska.pl Daily Mail and Mail on Sunday newspapers.
Recent data on RVU120 warrant further investigation in AML and HR-MDS biznespolska.pl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biznespolska.pl Daily Mail and Mail on Sunday newspapers.
Ryvu Therapeutics to Present Clinical and Preclinical Data on RVU120 at the 2023 European Hematology Association Congress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.